ATE531389T1 - Lipid- und distickstoffoxidverbindung als hilfsmittel zur erhöhung der impfstoffeffizienz - Google Patents
Lipid- und distickstoffoxidverbindung als hilfsmittel zur erhöhung der impfstoffeffizienzInfo
- Publication number
- ATE531389T1 ATE531389T1 AT06710759T AT06710759T ATE531389T1 AT E531389 T1 ATE531389 T1 AT E531389T1 AT 06710759 T AT06710759 T AT 06710759T AT 06710759 T AT06710759 T AT 06710759T AT E531389 T1 ATE531389 T1 AT E531389T1
- Authority
- AT
- Austria
- Prior art keywords
- acid
- antigen
- adjuvant
- lipid
- tool
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/205—Rhabdoviridae, e.g. rabies virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA200500856 | 2005-01-28 | ||
PCT/IB2006/050286 WO2006079989A2 (en) | 2005-01-28 | 2006-01-26 | Lipid and nitrous oxide combination as adjuvant for the enhancement of the efficacy of vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE531389T1 true ATE531389T1 (de) | 2011-11-15 |
Family
ID=36608667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06710759T ATE531389T1 (de) | 2005-01-28 | 2006-01-26 | Lipid- und distickstoffoxidverbindung als hilfsmittel zur erhöhung der impfstoffeffizienz |
Country Status (11)
Country | Link |
---|---|
US (2) | US20090010964A1 (de) |
EP (1) | EP1843787B1 (de) |
JP (1) | JP5159322B2 (de) |
CN (1) | CN101123982B (de) |
AT (1) | ATE531389T1 (de) |
CA (1) | CA2596920C (de) |
DK (1) | DK1843787T3 (de) |
ES (1) | ES2375267T3 (de) |
HK (1) | HK1118013A1 (de) |
WO (1) | WO2006079989A2 (de) |
ZA (1) | ZA200608016B (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101123982B (zh) | 2005-01-28 | 2015-06-17 | 西北大学 | 脂质和一氧化二氮组合作为用于增强疫苗功效的佐剂 |
US20100297249A1 (en) * | 2007-07-05 | 2010-11-25 | North-West University | Enhancement of the efficacy of therapeutic proteins |
US9815886B2 (en) | 2014-10-28 | 2017-11-14 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
JPWO2018225785A1 (ja) * | 2017-06-06 | 2020-04-16 | 株式会社Atomis | ワクチン組成物 |
SG11202006160RA (en) | 2018-01-02 | 2020-07-29 | Khloris Biosciences Inc | Ipsc-based vaccine as a prophylactic and therapeutic treatment for cancer |
US20220387569A1 (en) | 2021-06-01 | 2022-12-08 | Khloris Biosciences, Inc. | Induced pluripotent stem cell-based cancer vaccines |
CN116139266B (zh) * | 2023-04-14 | 2023-07-14 | 清华大学 | 长链不饱和脂肪酸在制备用于灭活疫苗的免疫增强剂中的用途 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB425406A (en) * | 1933-06-07 | 1935-03-07 | Vincent Gregory Walsh | Improvements in or relating to the manufacture of medical preparations of bacterial toxins |
US5585112A (en) * | 1989-12-22 | 1996-12-17 | Imarx Pharmaceutical Corp. | Method of preparing gas and gaseous precursor-filled microspheres |
JPH04279523A (ja) * | 1991-01-11 | 1992-10-05 | Nisshin Flour Milling Co Ltd | 免疫賦活油脂加工品 |
DK17093D0 (da) * | 1993-02-15 | 1993-02-15 | Lyfjathroun H F | Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder |
JPH06247849A (ja) * | 1993-02-25 | 1994-09-06 | Kao Corp | 免疫増強剤 |
FR2702373B1 (fr) * | 1993-03-08 | 1996-06-07 | Rhone Merieux | Emulsions vaccinales fluides eau-dans-l'huile contenant une huile métabolisable. |
JPH09121766A (ja) * | 1995-10-31 | 1997-05-13 | Meiji Milk Prod Co Ltd | n−6系列/n−3系列脂肪酸比率 を調整した乳児用食品 |
AU730495B2 (en) * | 1995-11-13 | 2001-03-08 | North West University | Administration media for analgesic, antiinflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs |
SE9602280D0 (sv) * | 1996-06-10 | 1996-06-10 | Pharmatrix Ab | Immunstimulerande lipidformulering |
US6696089B2 (en) * | 1998-09-03 | 2004-02-24 | Board Of Regents Of The University Of Nebraska | Nanogel networks including polyion polymer fragments and biological agent compositions thereof |
GB9820525D0 (en) * | 1998-09-21 | 1998-11-11 | Allergy Therapeutics Ltd | Formulation |
SE9900495D0 (sv) * | 1999-02-12 | 1999-02-12 | Pharmatrix Ab | Vaccine composition |
SE9900496D0 (sv) * | 1999-02-12 | 1999-02-12 | Pharmatrix Ab | Vaccine formulation |
JP2001029010A (ja) * | 1999-07-26 | 2001-02-06 | Snow Brand Milk Prod Co Ltd | 栄養組成物 |
JP2001245686A (ja) * | 1999-12-27 | 2001-09-11 | Osaka City | 脂肪酸低級アルコールエステルの製造方法 |
FR2804026B1 (fr) * | 2000-01-21 | 2004-06-11 | Merial Sas | Vaccination contre l'herpesvirose canine et vaccins |
CN100531799C (zh) * | 2000-07-19 | 2009-08-26 | 西北大学 | 增强抗感染剂作用的制剂和方法 |
CA2416650C (en) * | 2000-07-19 | 2010-09-21 | Pitmy International N.V. | Enhancement of the action of central and peripheral nervous system agents |
US7033813B2 (en) * | 2001-09-05 | 2006-04-25 | Trevor P Castor | Inactivated vaccines for aids and other infectious diseases |
CN1391954A (zh) * | 2002-07-09 | 2003-01-22 | 新疆大学生命科学与技术学院 | 增强核酸疫苗免疫的组合物及其生产方法和使用方法 |
CN101123982B (zh) | 2005-01-28 | 2015-06-17 | 西北大学 | 脂质和一氧化二氮组合作为用于增强疫苗功效的佐剂 |
-
2006
- 2006-01-26 CN CN200680003424.7A patent/CN101123982B/zh not_active Expired - Fee Related
- 2006-01-26 AT AT06710759T patent/ATE531389T1/de active
- 2006-01-26 ES ES06710759T patent/ES2375267T3/es active Active
- 2006-01-26 DK DK06710759.9T patent/DK1843787T3/da active
- 2006-01-26 EP EP06710759A patent/EP1843787B1/de not_active Not-in-force
- 2006-01-26 WO PCT/IB2006/050286 patent/WO2006079989A2/en active Application Filing
- 2006-01-26 JP JP2007552795A patent/JP5159322B2/ja not_active Expired - Fee Related
- 2006-01-26 CA CA2596920A patent/CA2596920C/en not_active Expired - Fee Related
- 2006-08-03 US US11/794,503 patent/US20090010964A1/en not_active Abandoned
- 2006-09-27 ZA ZA200608016A patent/ZA200608016B/xx unknown
-
2008
- 2008-08-13 HK HK08108995.0A patent/HK1118013A1/xx not_active IP Right Cessation
-
2013
- 2013-11-08 US US14/075,681 patent/US9585955B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA2596920C (en) | 2015-05-05 |
CN101123982B (zh) | 2015-06-17 |
ZA200608016B (en) | 2008-09-25 |
JP2008528570A (ja) | 2008-07-31 |
CA2596920A1 (en) | 2006-08-03 |
HK1118013A1 (en) | 2009-01-30 |
CN101123982A (zh) | 2008-02-13 |
DK1843787T3 (da) | 2012-02-20 |
US20140178431A1 (en) | 2014-06-26 |
US20090010964A1 (en) | 2009-01-08 |
ES2375267T3 (es) | 2012-02-28 |
JP5159322B2 (ja) | 2013-03-06 |
US9585955B2 (en) | 2017-03-07 |
EP1843787A2 (de) | 2007-10-17 |
EP1843787B1 (de) | 2011-11-02 |
WO2006079989A3 (en) | 2006-10-12 |
WO2006079989A2 (en) | 2006-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE531389T1 (de) | Lipid- und distickstoffoxidverbindung als hilfsmittel zur erhöhung der impfstoffeffizienz | |
NZ608755A (en) | Plant support formulation, vehicle for the delivery and translocation of phytologically beneficial substances and compositions containing same | |
DK1476171T3 (da) | Transport af nukleinsyresubstanser | |
ATE384518T1 (de) | Zusammensetzungen enthaltend phytosterol- und policosanolester von fettsäuren zur herabsetzung des cholesterol- und triglyceridspiegels | |
WO2009154369A3 (ko) | 오메가-3계 고도불포화 지방산의 고순도 정제방법 | |
KR20070104596A (ko) | 크립테코디늄 속으로 부터의 항산화 추출물의 생산 및 용도 | |
DE602004021396D1 (de) | Rwendung von glycerin | |
CA2595917A1 (en) | Method for producing a dha-containing fatty acid composition | |
KR20130111233A (ko) | 리파아제에 의한 고도 불포화 지방산 함유 유지의 제조 방법 | |
US9918953B2 (en) | Composition containing eicosapentaenoic acid alkyl ester, and method for producing same | |
Zhang et al. | Concentration of omega-3 polyunsaturated fatty acids from oil of Schizochytrium limacinum by molecular distillation: optimization of technological conditions | |
Patel et al. | Novel biorefinery approach aimed at vegetarians reduces the dependency on marine fish stocks for obtaining squalene and docosahexaenoic acid | |
WO2002005850A3 (en) | Enhancement of the action of anti-infective agents | |
AR076184A1 (es) | Formulaciones farmaceuticas que comprenden 9-cis-retinil esteres en un vehiculo lipidico. metodo. | |
PL366696A1 (en) | Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers | |
CL2022003599A1 (es) | Procedimiento de aislamiento de lípidos a partir de una biomasa que contiene lípidos | |
JP2007089522A5 (de) | ||
No et al. | Pinolenic acid as a new source of phyto‐polyunsaturated fatty acid | |
JP2022009143A (ja) | 住血吸虫症を予防かつ/または治療するための組成物および方法 | |
CO2017009084A2 (es) | Recuperación de tocoferoles/tocotrienoles, glicerina, esteroles y ésteres de ácidos grasos a partir de destilado de aceite vegetal y el proceso de la misma | |
Rahman et al. | Synthesis and characterization of 2-monoacylglycerols from Canarium oil (Canarium indicum) | |
RU2015129719A (ru) | Лептоспиры с повышенной антигенной массой | |
JPWO2020050304A1 (ja) | リパーゼ加水分解反応を用いるドコサヘキサエン酸含有グリセリドの製造方法 | |
CN108018320A (zh) | 一种使用固定化脂肪酶富集藻油中的gla的方法 | |
RU2006147043A (ru) | Способ получения активной добавки для косметических средств и пищевых добавок |